Comparison of Surgery Risk According to Post‐EBD Biologic Therapy In the overall cohort, surgery‐free survival showed an increasing trend in patients treated with biologic therapy after EBD compared with those treated with conventional therapy only, but the difference was not statistically significant (log‐rank test, p = 0.0749) (Figure 5A ).
← all excerpts
Enteroscopic Balloon Dilation in Small Bowel Stricturing Crohn's Disease: Long-Term Outcomes and Risk Factors for Surgery in a Single-Center Prospective Observational Study.
1
—
—